BioCentury This Week
en
us
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.
For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
More details
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.
For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Episodes
Page 7 · 50 per page
Published 2021-07-26
Ep. 69 - Allaying Aduhelm Concerns, Plus Master Protocols, Arvinas-Pfizer
14 min
More description
Extract Knowledge
Listen elsewhere
Published 2021-07-06
Ep. 66 - Biotechs hit 3Q with Coolers Full of Cash; plus Distillery on Tap
21 min
More description
Extract Knowledge
Listen elsewhere
Published 2021-06-28
Ep. 65 - Optimism for Intellia's CRISPR Breakthrough, Concerns about Aduhelm
22 min
More description
Extract Knowledge
Listen elsewhere
Published 2021-06-23
Ep. 64 - Amyloid Analysis: Stress Testing FDA's Logic on Surrogate Endpoint
18 min
More description
Extract Knowledge
Listen elsewhere
Published 2021-06-14
Ep. 62 - Reflecting on the Implications of Aduhelm's Approval: A BioCentury Podcast
18 min
More description
Extract Knowledge
Listen elsewhere
Published 2021-05-03
Ep. 56 - FDA’s ODAC Bind; plus NK Cell Engagers and Company Creation in Europe
20 min
More description
Extract Knowledge
Listen elsewhere
Published 2021-04-26
Ep. 55 - German Plays Deliver on Data, plus Accelerated Approval on Trial
19 min
More description
Extract Knowledge
Listen elsewhere
Published 2021-04-19
Ep. 54 - Patient Groups’ Pandemic Pain; plus Voters’ Rights and Synthetic Lethality
25 min
More description
Extract Knowledge
Listen elsewhere
Published 2021-04-12
Ep. 53 - Competence & Continuity at CDER; plus BIO 3.0, AACR and 2Q Preview
23 min
More description
Extract Knowledge
Listen elsewhere
Published 2021-04-05
Ep. 52 - Memories of John Martin, plus AACR's Hot Targets & Bio€quity Europe Preview
23 min
More description
Extract Knowledge
Listen elsewhere
Published 2021-03-22
Ep. 50 - FTC & the Zombie Pharma Dinosaurs; Plus: RIP José Baselga, NCATS & SPACs
18 min
More description
Extract Knowledge
Listen elsewhere
Published 2021-03-15
Ep. 49 - Vaccine Vexed; Plus Assessing Lilly's Alzheimer's Data & PDUFA Preview
20 min
More description
Extract Knowledge
Listen elsewhere
Published 2021-03-08
Ep. 48 - New Modality Deep Dive; plus Sharpless Speaks & Five Prime Scores
20 min
More description
Extract Knowledge
Listen elsewhere
Published 2021-03-01
Ep. 47 - Whither Woodcock; plus Refresh for German Biotech & Modalities to Market
25 min
More description
Extract Knowledge
Listen elsewhere
Published 2021-02-22
Ep. 46 - Pipeline plays for BMS, Rigel; plus J&J's vaccine panel & access for Africa
21 min
More description
Extract Knowledge
Listen elsewhere
Published 2021-02-08
Ep. 44 - Biotech's IPO blizzard, plus GameStop, Porter Report & Vaccine Guidance
19 min
More description
Extract Knowledge
Listen elsewhere
Published 2020-12-14
Ep. 36 - Vaccines march forward & CAR Ts move earlier: a BioCentury podcast
17 min
Transcript
More description
Extract Knowledge
Listen elsewhere
Show details
Episodes
377
Transcripts
83
22% coverage
Missing transcripts
294
With chapters
280